Clinical Trials Browser

antineoplaston AS 2-1 × Tumor-Agnostic × Clear all

NCT00003526 2020-12-17

Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin

Phase 2 Terminated

8 enrolled 5 charts

Neoplasms, Unknown Primary